Cargando…

Seroprevalence of SARS-Coronavirus 2 among asymptomatic healthy blood donors from healthcare and non-healthcare settings: Implications for safety of blood donors and blood collection staff during blood donation

INTRODUCTION: SARS-Coronavirus-2 pandemic has adversely affected blood supply as potential blood donors were afraid of acquiring infection in hospital settings. We aimed to compare COVID-19 seroprevalence among asymptomatic blood donors from healthcare and non-healthcare setting to analyse the diffe...

Descripción completa

Detalles Bibliográficos
Autores principales: Pandey, Hem Chandra, Dhiman, Yashaswi, C.S., Chippy, Coshic, Poonam, Jain, Pankaj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948824/
https://www.ncbi.nlm.nih.gov/pubmed/33752991
http://dx.doi.org/10.1016/j.transci.2021.103118
_version_ 1783663450021429248
author Pandey, Hem Chandra
Dhiman, Yashaswi
C.S., Chippy
Coshic, Poonam
Jain, Pankaj
author_facet Pandey, Hem Chandra
Dhiman, Yashaswi
C.S., Chippy
Coshic, Poonam
Jain, Pankaj
author_sort Pandey, Hem Chandra
collection PubMed
description INTRODUCTION: SARS-Coronavirus-2 pandemic has adversely affected blood supply as potential blood donors were afraid of acquiring infection in hospital settings. We aimed to compare COVID-19 seroprevalence among asymptomatic blood donors from healthcare and non-healthcare setting to analyse the difference in exposure level of each group as well as the risk of acquiring infection during the process of blood donation. MATERIAL AND METHODS: Analysis of whole blood donors tested for SARS-CoV-2 IgG antibodies was carried out after categorizing them into healthcare workers (HCW) and non-healthcare workers (NHCW). NHCW were further categorized into residents of containment and non-containment zones and seroprevalence analyzed. Seroprevalence among different ABO blood groups was also analyzed. RESULTS: 1191 blood donors were tested for SARS-CoV-2 antibodies with 9.5 % seropositivity. Significantly lower seropositivity of 3.2 % (p < 0.001) was observed among HCW as compared to 10.9 % seropositivity in NHCW. Among NHCW no difference in seropositivity was observed based on residence in containment or non-containment zone. Significantly higher (p = 0.012) seroprevalence was observed among A blood group donors (12.5 %) as compared to O blood group donors (6.8 %). CONCLUSION: Results suggests that a blood donor, in a hospital setting is less likely to be exposed to COVID-19 disease than when participating in activities of daily living. It is postulated that the lower seroprevalence among HCW as compared to NHCW reflects differences in knowledge and practice of preventive measures among these groups. The findings should instil confidence among blood donors and motivate them to donate blood without fear.
format Online
Article
Text
id pubmed-7948824
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-79488242021-03-11 Seroprevalence of SARS-Coronavirus 2 among asymptomatic healthy blood donors from healthcare and non-healthcare settings: Implications for safety of blood donors and blood collection staff during blood donation Pandey, Hem Chandra Dhiman, Yashaswi C.S., Chippy Coshic, Poonam Jain, Pankaj Transfus Apher Sci Article INTRODUCTION: SARS-Coronavirus-2 pandemic has adversely affected blood supply as potential blood donors were afraid of acquiring infection in hospital settings. We aimed to compare COVID-19 seroprevalence among asymptomatic blood donors from healthcare and non-healthcare setting to analyse the difference in exposure level of each group as well as the risk of acquiring infection during the process of blood donation. MATERIAL AND METHODS: Analysis of whole blood donors tested for SARS-CoV-2 IgG antibodies was carried out after categorizing them into healthcare workers (HCW) and non-healthcare workers (NHCW). NHCW were further categorized into residents of containment and non-containment zones and seroprevalence analyzed. Seroprevalence among different ABO blood groups was also analyzed. RESULTS: 1191 blood donors were tested for SARS-CoV-2 antibodies with 9.5 % seropositivity. Significantly lower seropositivity of 3.2 % (p < 0.001) was observed among HCW as compared to 10.9 % seropositivity in NHCW. Among NHCW no difference in seropositivity was observed based on residence in containment or non-containment zone. Significantly higher (p = 0.012) seroprevalence was observed among A blood group donors (12.5 %) as compared to O blood group donors (6.8 %). CONCLUSION: Results suggests that a blood donor, in a hospital setting is less likely to be exposed to COVID-19 disease than when participating in activities of daily living. It is postulated that the lower seroprevalence among HCW as compared to NHCW reflects differences in knowledge and practice of preventive measures among these groups. The findings should instil confidence among blood donors and motivate them to donate blood without fear. Elsevier Ltd. 2021-06 2021-03-11 /pmc/articles/PMC7948824/ /pubmed/33752991 http://dx.doi.org/10.1016/j.transci.2021.103118 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Pandey, Hem Chandra
Dhiman, Yashaswi
C.S., Chippy
Coshic, Poonam
Jain, Pankaj
Seroprevalence of SARS-Coronavirus 2 among asymptomatic healthy blood donors from healthcare and non-healthcare settings: Implications for safety of blood donors and blood collection staff during blood donation
title Seroprevalence of SARS-Coronavirus 2 among asymptomatic healthy blood donors from healthcare and non-healthcare settings: Implications for safety of blood donors and blood collection staff during blood donation
title_full Seroprevalence of SARS-Coronavirus 2 among asymptomatic healthy blood donors from healthcare and non-healthcare settings: Implications for safety of blood donors and blood collection staff during blood donation
title_fullStr Seroprevalence of SARS-Coronavirus 2 among asymptomatic healthy blood donors from healthcare and non-healthcare settings: Implications for safety of blood donors and blood collection staff during blood donation
title_full_unstemmed Seroprevalence of SARS-Coronavirus 2 among asymptomatic healthy blood donors from healthcare and non-healthcare settings: Implications for safety of blood donors and blood collection staff during blood donation
title_short Seroprevalence of SARS-Coronavirus 2 among asymptomatic healthy blood donors from healthcare and non-healthcare settings: Implications for safety of blood donors and blood collection staff during blood donation
title_sort seroprevalence of sars-coronavirus 2 among asymptomatic healthy blood donors from healthcare and non-healthcare settings: implications for safety of blood donors and blood collection staff during blood donation
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948824/
https://www.ncbi.nlm.nih.gov/pubmed/33752991
http://dx.doi.org/10.1016/j.transci.2021.103118
work_keys_str_mv AT pandeyhemchandra seroprevalenceofsarscoronavirus2amongasymptomatichealthyblooddonorsfromhealthcareandnonhealthcaresettingsimplicationsforsafetyofblooddonorsandbloodcollectionstaffduringblooddonation
AT dhimanyashaswi seroprevalenceofsarscoronavirus2amongasymptomatichealthyblooddonorsfromhealthcareandnonhealthcaresettingsimplicationsforsafetyofblooddonorsandbloodcollectionstaffduringblooddonation
AT cschippy seroprevalenceofsarscoronavirus2amongasymptomatichealthyblooddonorsfromhealthcareandnonhealthcaresettingsimplicationsforsafetyofblooddonorsandbloodcollectionstaffduringblooddonation
AT coshicpoonam seroprevalenceofsarscoronavirus2amongasymptomatichealthyblooddonorsfromhealthcareandnonhealthcaresettingsimplicationsforsafetyofblooddonorsandbloodcollectionstaffduringblooddonation
AT jainpankaj seroprevalenceofsarscoronavirus2amongasymptomatichealthyblooddonorsfromhealthcareandnonhealthcaresettingsimplicationsforsafetyofblooddonorsandbloodcollectionstaffduringblooddonation